We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Eden Research Plc | LSE:EDEN | London | Ordinary Share | GB0001646941 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 4.25 | 4.00 | 4.50 | 4.25 | 4.25 | 4.25 | 245,065 | 08:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Biological Pds,ex Diagnstics | 1.83M | -2.24M | -0.0042 | -10.12 | 22.67M |
Date | Subject | Author | Discuss |
---|---|---|---|
09/10/2019 08:26 | Nearly a fifth of all food and drink launches in Europe are organic – Mintel New research from Mintel shows that Europe is leading the way in organic food and drink innovation, with almost a fifth of all food and drink products launched in Europe carrying an organic claim. In the 10 years to July 2019, the number of European food and drink launches with an organic claim has shot up from 9% to 17%, satisfying Europe’s hunger for organics. Current leading innovators include France (accounting for 22% of all organic launches in Europe between August 2018 and July 2019), Germany (20%) and Spain (9%). But it’s not just Europe that is enjoying a greater variety of organic food and drinks; North America has also experienced an impressive increase in organic launches. The number of organic food and drink products has grown from 9% in 2009 to 15% in 2019 (Aug 2018-July 2019). While the availability of organic food and drink products in Asia Pacific, Latin America, the Middle East and Africa has risen slightly, less than one in twenty (4%) food and drink launches between August 2018 and July 2019 carried an organic claim in each of these regions. This is up from 3% in Asia Pacific and Latin America, and 2% in the Middle East and Africa ten years ago. | supersonico | |
09/10/2019 07:30 | We should practise Fraudy..give your commentary more relevance. Fraudy..Look how poor Sipcam have been.. Mevalone sales hardly make Eden look like an important Partner. Supersonico.. That's fair comment Fraudy we were promised a lot, revenues and the SustainE deals are slower than expected to arrive. I'm hoping Cedroz..being promoted by a company 20 times bigger than Sipcam,(Eastman) and selling into a market where conventional chemistry is being hollowed out by Regulatory pressure.. will have more of an impact on the bottom line. Fraudy ..Why did you bring up C....Z you know I can't say that word. Supersonico..oh sorry I forgot..lets talk Death Spiral Finace and Bucket shop placings. | supersonico | |
08/10/2019 17:28 | bjlk, 4 days for me. | weyweyumfozo | |
08/10/2019 16:14 | Direction of travel.. News. Interesting Bio fungicide application with Sumitomo partner Nufarm etal who both look to be progressing work on New Fungicide solutions. High-tech sustainable protection for key Australian crops. | supersonico | |
08/10/2019 16:11 | I am about 10 days waiting... you?? | bjlk | |
08/10/2019 15:23 | bjlk, I have also emailed them and have yet to receive a reply. | weyweyumfozo | |
08/10/2019 13:53 | I am a long term holder but why is there no effort by management to try and stop this share price falling, no justification for TT and just deafening silence... but guess what they are tweeting ... they do not even have the respect to reply to emails from a shareholder.. how else are we supposed to communicate with the company except through advfn... brilliant management!! maybe it will all happen in short order along with asteroid jam tomorrow | bjlk | |
08/10/2019 12:46 | Lonely Lube Cedroz.. not a peep. SustainE collaborators.. not a peep. Your really not getting my Drift are you Fraudy? At least try and appear credible. | supersonico | |
08/10/2019 12:31 | That's unlikely to happen until we see Cedroz/Mevalone numbers boost Revenue or Strategic investor details improve over all capacity and prospects. Eastman promotion will be the biggest Eden associated PR to date imo. New Ced/Mev country approvals look like they are being managed imo. TT/Bayer/SustainE Parallel delays I believe has a while to resolution ..but worth the wait as it will imo incorporate conventional chemistry field applications for Cotton/ Wheat/ Soya amongst others . The next report regarding TT Headlice will be interesting. Something like a Short order Jam Tomorrow Asteroid hit the Fork truck loading the Lorry. All wild guesses all the wild time. | supersonico | |
08/10/2019 12:25 | I'd prefer to sell on the up. Eden's been "dipping" for far too long. Powerscourt, what �3,000-�4,000 a month to "PR" the interim and annual reports. Not a required cost by LSE-AIM and a total waste of money. | investingisatrickygame | |
08/10/2019 12:21 | Buy on the Dip. | supersonico | |
08/10/2019 12:04 | Cenkos "Killing It" What a very apt title! Private sellers dictating the price and getting ever more frustrated. And the Company still ignores the private investor. | investingisatrickygame | |
08/10/2019 11:42 | Fraudy, I'm keen to buy more shares cheaper so Lube would be welcome ..so please get serious with the campaign. It has the air of defeat about it..you need to show more commitment with more Mancasts and more Lube Gimmickry. I have self imposed NDA's so have a good idea why we are waiting and what we are waiting for so would appreciate help lowering my average. Thanks in advance. | supersonico | |
08/10/2019 11:07 | So where are the Lube..? A serious Fraudy always brings Lube. Lonely Lube.. Fraudy not serious. | supersonico | |
08/10/2019 10:12 | With #harvest ongoing, there is a race to beat #botrytis with the particularly mild and wet conditions across much of Europe. #Mevalone provides flexible, late season protection with just a 3 day PHI. | brucie5 | |
07/10/2019 16:48 | 10_New Nematocide based on terpenes for the protection of solanaceae and cucurbits from Nematodi galligeni. E. Medico1, E. Van Hende1 , K. El Ouadi1, M. M.Villagra1 The product is an innovative suspension of capsules (CS) based on thymol and geraniol (better known as terpenes) called Cedroz®. These terpenes have a nematocidal action identified, developed and proven by Eden Research plc and Eastman Chemical B.V. Thymol and geraniol are respectively phenols and alcohols with the characteristic of being volatile, lipophilic and insoluble in water. Thanks to the innovative capsule formulation that promotes suspensibility without the use of solvents, the terpenes can be dissolved in solution and applied to the soil with a slow and gradual release. The mode of action of thymol and geraniol is explained by their synergistic interaction with the lipid substances contained in the membranes of the cell walls of the nematodes and their eggs. In the experimental tests on solanaceae and cucurbits Cedroz showed to have a satisfactory efficacy comparable to that of the existing post-transplantation control solutions. Thymol and geraniol have a favorable toxicological, ecotoxicological and environmental profile. The Cedroz commercial product will have no shortage and will be exempt from MRLs. ……&hel Il prodotto è una innovativa sospensione di capsule (CS) a base di timolo e geraniolo (meglio conosciuti come terpeni) denominata Cedroz®. Questi terpeni hanno un’azione nematocida identificata, sviluppata e comprovata da Eden Research plc e Eastman Chemical B.V. Timolo e geraniolo sono rispettivamente fenoli ed alcoli con la caratteristica di essere volatili, lipofili e insolubili in acqua. Grazie all’innovativa formulazione di capsule che promuove la sospensibilità | supersonico | |
07/10/2019 14:13 | Super, Of course Powerscourt et al are responsible too. But the answer to that one is simple. Eden pays us X and for that they get Y. If they want Z, then pay us more money per month. They work like lawyers: hours and rates. | investingisatrickygame | |
07/10/2019 13:17 | Investing, If the company image becomes poor then perhaps we should sack lofty Powerscourt and not pay Shore and Cenkos to produce damp useless incredulous reports that loose pipeline products without explanation. That would be a start before looking to BB contributors for a scapegoat. As for Spats putting off investors ..I'm not persuaded..Spats are irrelevant to most especially those who do research. | supersonico | |
07/10/2019 11:37 | And this is why Eden's investor communications is so poor and yet, so necessary moving forward. Eden says nothing, but very rarely says something. Thus the Eden website is static, unengaging and invariably not worth a visit. What ends up replacing Eden's website is this bulletin board and others like it and it is the chatter on these boards that become the image of the Company to those looking to learn about Eden. (Let's not forget the Company mantra is that Twitter is for the trade, not investors!!!!). So the Company image becomes poor. The investment opportunity among all of this discussion becomes off-putting. The board think those posting on here are idiots and with little real understanding of Eden (often wrong in my opinion and of their own doing) and as such, they have little time for them/us and subsequently court the institutions who are not yet listening, but Sean and Alex are happier speaking with these individuals rather than us. For the record, I know of many here, both posters and watchers who have held very good corporate careers turning over more revenue than Eden and also some who have come through the start-up phase. they should be acknowledged and somewhat respected, but spats on boards just end up devaluing all of us. | investingisatrickygame |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions